pet/ct Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
New/Updated Trials
Online Trials
Age Group

Male only (90)
Female only (41)
Any (445)

Phase 1 (70)
Phase 2 (131)
Phase 3 (28)
Phase 4 (7)
Phase 1/2 (27)
Phase 2/3 (13)
Unknown (300)

Interventional (467)
Observational (107)

Peking Union Medical College Hospital (17)
University of Pennsylvania (16)
M.D. Anderson Cancer Center (14)
First Affiliated Hospital of Fujian Medical University (12)
National Cancer Institute (NCI) (12)
Beijing Cancer Hospital (11)
ECOG-ACRIN Cancer Research Group (8)
Institut Cancerologie de l'Ouest (8)
Jonsson Comprehensive Cancer Center (8)
University of Aarhus (7)
Wuhan Union Hospital, China (7)
Abramson Cancer Center of the University of Pennsylvania (6)
Baylor College of Medicine (6)
Mayo Clinic (6)
Memorial Sloan Kettering Cancer Center (6)
Sun Yat-sen University (6)
University Health Network, Toronto (6)
University Hospital, Brest (6)
British Columbia Cancer Agency (5)
Fudan University (5)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (5)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (5)
Universitair Ziekenhuis Brussel (5)
University of Wisconsin, Madison (5)
Washington University School of Medicine (5)
Centre de recherche du Centre hospitalier universitaire de Sherbrooke (4)
Fifth Affiliated Hospital, Sun Yat-Sen University (4)
Hoag Memorial Hospital Presbyterian (4)
Ohio State University (4)
Peter MacCallum Cancer Centre, Australia (4)
Radboud University (4)
RenJi Hospital (4)
Stanford University (4)
The First Affiliated Hospital of Xiamen University (4)
Turku University Hospital (4)
University Hospital, Ghent (4)
University of Alabama at Birmingham (4)
University of Lausanne Hospitals (4)
Zhongnan Hospital (4)
Brigham and Women's Hospital (3)
CellSight Technologies, Inc. (3)
Columbia University (3)
IRCCS San Raffaele (3)
Massachusetts General Hospital (3)
National Heart, Lung, and Blood Institute (NHLBI) (3)
National Institute of Neurological Disorders and Stroke (NINDS) (3)
Oslo University Hospital (3)
Radboud University Medical Center (3)
Shengjing Hospital (3)
UNC Lineberger Comprehensive Cancer Center (3)
University Hospital, Basel, Switzerland (3)
University of Alberta (3)
University of California, Davis (3)
University of Southern California (3)
University of Utah (3)
University of Washington (3)
Weill Medical College of Cornell University (3)
Anhui Provincial Hospital (2)
Centre Antoine Lacassagne (2)
Centre hospitalier de l'Université de Montréal (CHUM) (2)
Dana Mathews (2)
Duke University (2)
Emory University (2)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2)
Gruppo Oncologico del Nord-Ovest (2)
Gustave Roussy, Cancer Campus, Grand Paris (2)
Indiana University (2)
Istituto Clinico Humanitas (2)
Leiden University Medical Center (2)
Montreal Heart Institute (2)
NRG Oncology (2)
National Institute of Allergy and Infectious Diseases (NIAID) (2)
National Institute of Mental Health (NIMH) (2)
National Taiwan University Hospital (2)
Norwegian University of Science and Technology (2)
Novartis Pharmaceuticals (2)
Odense University Hospital (2)
Ohio State University Comprehensive Cancer Center (2)
Olivia Newton-John Cancer Research Institute (2)
Rigshospitalet, Denmark (2)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (2)
Shanghai Proton and Heavy Ion Center (2)
Shanghai Zhongshan Hospital (2)
Tata Medical Center (2)
Tata Memorial Hospital (2)
The University of Hong Kong (2)
University College, London (2)
University Hospital Tuebingen (2)
University Hospital, Bordeaux (2)
University Medical Center Groningen (2)
University of California, Los Angeles (2)
University of California, San Diego (2)
University of Colorado, Denver (2)
University of Michigan Rogel Cancer Center (2)
University of Saskatchewan (2)
VA Office of Research and Development (2)
Vastra Gotaland Region (2)
ABX advanced biochemical compounds GmbH (1)
AC Camargo Cancer Center (1)
AHS Cancer Control Alberta (1)

No (503)
Yes (73)

Updated trials (29)

No (576)

Adult (18+) (572)
Pediatric (Under 18) (61)

I am/have/had

I am/have/hadradical prostatectomy

I am/have/hadbladder cancer

I am/have/hadliver disease

I am/have/haddiffuse large b-cell lymphoma

I am/have/hadbone marrow procedure

I am/have/hadlymphoma

I am/have/hadblood test

I am/have/hadpet/ct scan

I am/have/hadpositron emission tomography/computed tomography

I am/have/hadbreast cancer

I am/have/hadstereotactic body radiation therapy

I am/have/haddementia

I am/have/hadandrogen suppression

I am/have/haddiagnostic procedures

I am/have/hadbrachytherapy

I am/have/hadfasting

I am/have/hadepidermal growth factor receptor

I am/have/hadamyloidosis

I am/have/hadplatelet count

I am/have/hadanticoagulants

added new label for I am/have/had

I am looking for

I am looking fordaratumumab

I am looking forcyclin d1

I am looking formonoclonal protein

I am looking forbendamustine

I am looking forimmune checkpoint inhibitor

I am looking forprednisone

I am looking forendocrine therapy

I am looking fortestosterone

I am looking foririnotecan

I am looking forAccepts healthy volunteers

I am looking for68ga-dotatoc

I am looking forabiraterone

I am looking forchromogranin a

I am looking forfludarabine

I am looking forgemcitabine

I am looking forflorbetapir

I am looking foradrenaline

I am looking forcapecitabine

I am looking fordopamine

I am looking forpituitary

added new label for I am looking for

Advanced Filters

Found 576 clinical trials

For Seniors
For adults
Recruiting in 100s
Interventional Study
For Males
Family Medicine
Recruiting

Dutch National Randomized Study: PSMA-PET/CT as a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients

To determine if the use of Prostate-Specific Membrane Antigen Positron Emission Computer Tomography (PSMA PET/CT) as a selection tool for performing extended lymph node dissection (ePLND) for

0 views
25 Aug, 2021
1 location

Phase 2
Recruiting in 100s
Interventional Study
For Males
Family Medicine
Recruiting

Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence

This study evaluates the value of Gallium-68 labeled PSMA (68Ga-PSMA) for PET/CT imaging of prostate cancer recurrence. 68Ga-PSMA is a radioactive molecule, which binds to prostate cancer cells

ct scan

brachytherapy

68ga-psma-11

prostatectomy

prostate adenocarcinoma

0 views
26 Feb, 2022
1 location

Multi-country trial
Phase 2
Recruiting in 100s
Interventional Study
For Males
Family Medicine
Recruiting

Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection (GuideView)

histopathology assessments. Approximately 195 participants will be enrolled to ensure that at least 156 participants are evaluable (i.e. have both an evaluable PET/CT scan and histopathology assessment

0 views
23 Jul, 2022
10 locations

Phase 4
Recruiting in 100s
Interventional Study
For all genders
Cardiovascular Diseases
Recruiting

Screening for Cancer in Patients With Unprovoked VTE

Open and multicenter randomized clinical trial (1:1) comparing limited screening with extended screening with the performance of Positron emission tomography-computed tomography (PET-CT) scan in

embolism

clot

thrombosis

deep vein thrombosis

deep venous thrombosis of lower extremity

0 views
18 Dec, 2021
9 locations

Multi-country trial
For Seniors
For adults
Recruiting in 100s
Interventional Study
For all genders
Recruiting

Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL)

> Hypothesis: The radiation dose and treatment volume can be safely reduced from 30 Gy to 20 Gy while maintaining high rates of local control in patients who had a negative PET-CT scan following rituximab

ct scan

high grade b-cell lymphoma

anthracyclines

chemoimmunotherapy

rituximab

8 views
27 Jul, 2022
13 locations

Phase 3
For pediatric ages
For Seniors
Recruiting in 1000s
Interventional Study
For all genders
Hematology
Recruiting

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma (RADAR)

Eligible patients will be randomised to receive either ABVD or A2VD chemotherapy. An interim PET-CT scan will be performed after 2 cycles of treatment, which will be used to adapt

lymphoma

doxorubicin

ejection fraction

classical hodgkin lymphoma

vinblastine

2 views
09 Jun, 2022
7 locations

Phase 3
Recruiting in 1000s
Interventional Study
For all genders
Recruiting

Multicentric Comparative Study Between a Conventional and an Intensive Follow up Strategy After Treatment of a Head and Neck Squamous Cell Carcinoma (SURVEILL'ORL)

imaging including PET-CT for patients N2) performed 2 to 4 months after the end of treatment. The randomization ratio is 1:1.

squamous cell carcinoma

cancer

0 views
03 Mar, 2022

Multi-country trial
Recruiting in 1000s
Interventional Study
For all genders
Cardiovascular Diseases
Recruiting

Screening for Occult Malignancy in Patients With Unprovoked Venous Thromboembolism (MVTEP2/SOME2)

occult cancer especially based on FDG PET/CT, and suggests that the best target population for cancer screening would be patients with unprovoked VTE older than 50 years of age (6.7% in patients aged 50

cancer

26 views
22 Mar, 2022
15 locations

Phase 3
Recruiting in 100s
Interventional Study
For all genders
Endocrinology
Recruiting

18F-DOPA II - PET Imaging Optimization

A single centre non-randomized, non-blinded phase III prospective cohort study of 18F-DOPA PET/CT imaging in specific patient populations: Pediatric patients (less than 18 years

dementia

parkinson's disease

dopa

8 views
03 May, 2022
1 location

Phase 2
Recruiting in 100s
Interventional Study
For all genders
Neurology
Recruiting

Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

PET/CT) can further detect tumors. Eligibility People ages 12 and older with VHL that causes tumors and cysts to grow in the pancreas Design

genetic testing

ct scan

pet/ct scan

dotatate

neuroendocrine tumor

0 views
29 Jul, 2022
1 location